期刊
BRAIN RESEARCH BULLETIN
卷 115, 期 -, 页码 23-29出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.brainresbull.2015.04.005
关键词
GPR39; Zinc; NMDA; Serotonine; Noradrenaline; Depression
资金
- Funds for Statutory Activity of the Jagiellonian University Medical College in Krakow, Poland [K/ZDS/004699]
- Lundbeck Foundation [R77-2010-7203] Funding Source: researchfish
- Novo Nordisk Fonden [NNF14OC0013197] Funding Source: researchfish
Zinc can regulate neural function in the brain via the GPR39 receptor. In the present study we investigated whether inhibition of serotonin, noradrenaline and dopamine synthesis and potentialization of glutamate, via administration of p-chlorophenylalanine (pCPA), alpha-methyl-p-tyrosine (alpha MT) and N-methyl-D-aspartatic acid (NMDA), respectively, would cause changes in GPR39 levels. Western blot analysis showed GPR39 up-regulation following 3-day administration of alpha MT and NMDA in the frontal cortex, and GPR39 down-regulation following 10-day administration of pCPA, alpha MT, and NMDA in the hippocampus of CD-1 mice. There were no changes in serum zinc levels. Additionally, we investigated tryptophan, tyrosine and glutamate concentrations in the hippocampus and frontal cortex of GPR39 knockout (GPR39 KO) mice. Liquid chromatography-mass spectrometry (Lc-MS) showed a significant decrease in tryptophan and tyrosine, but not in glutamate concentrations in the hippocampus of GPR39 KO mice. There were no changes in the frontal cortex between GPR39 KO and wild type. These results indicate a possible role of the GPR39 receptor in monoaminergic and glutamatergic neurotransmission, which plays an important role in the pathophysiology of depression. (C) 2015 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据